CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 401818-401949 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T57169","span":{"begin":0,"end":131},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We found that IL-12 suppressed EAE clinically and pathologically when administered during the early induction phase of the disease."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T120","span":{"begin":0,"end":131},"obj":"Sentence"}],"text":"We found that IL-12 suppressed EAE clinically and pathologically when administered during the early induction phase of the disease."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T779","span":{"begin":31,"end":34},"obj":"Phenotype"}],"attributes":[{"id":"A779","pred":"hp_id","subj":"T779","obj":"http://purl.obolibrary.org/obo/HP_0002383"}],"text":"We found that IL-12 suppressed EAE clinically and pathologically when administered during the early induction phase of the disease."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2654","span":{"begin":31,"end":34},"obj":"Disease"},{"id":"T34737","span":{"begin":31,"end":34},"obj":"Disease"}],"attributes":[{"id":"A2654","pred":"mondo_id","subj":"T2654","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A2655","pred":"mondo_id","subj":"T2654","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A2656","pred":"mondo_id","subj":"T2654","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A66409","pred":"mondo_id","subj":"T34737","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A73666","pred":"mondo_id","subj":"T34737","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A77853","pred":"mondo_id","subj":"T34737","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"}],"text":"We found that IL-12 suppressed EAE clinically and pathologically when administered during the early induction phase of the disease."}